Medidata Solutions (NASDAQ:MDSO) Upgraded to “Neutral” by JPMorgan Chase & Co.

Medidata Solutions (NASDAQ:MDSO) was upgraded by investment analysts at JPMorgan Chase & Co. from an “underweight” rating to a “neutral” rating in a research note issued to investors on Wednesday, The Fly reports.

Other analysts also recently issued reports about the company. SunTrust Banks downgraded Medidata Solutions from a “buy” rating to a “hold” rating and set a $79.00 target price on the stock. in a research report on Wednesday, April 24th. Wells Fargo & Co downgraded Medidata Solutions from an “outperform” rating to a “market perform” rating and set a $90.00 target price on the stock. in a research report on Tuesday, April 23rd. William Blair downgraded Medidata Solutions from an “outperform” rating to a “market perform” rating in a research report on Wednesday. Guggenheim downgraded Medidata Solutions from a “buy” rating to a “neutral” rating in a research report on Wednesday. Finally, Piper Jaffray Companies boosted their target price on Medidata Solutions from $83.00 to $96.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 30th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. Medidata Solutions currently has an average rating of “Hold” and a consensus price target of $84.23.

Medidata Solutions stock opened at $94.75 on Wednesday. The company has a current ratio of 2.57, a quick ratio of 2.57 and a debt-to-equity ratio of 0.29. The company has a market capitalization of $5.90 billion, a P/E ratio of 98.70, a price-to-earnings-growth ratio of 8.43 and a beta of 1.31. Medidata Solutions has a 1-year low of $60.10 and a 1-year high of $98.60.

Medidata Solutions (NASDAQ:MDSO) last posted its earnings results on Tuesday, April 30th. The company reported $0.45 EPS for the quarter, topping the Zacks’ consensus estimate of $0.12 by $0.33. The company had revenue of $173.50 million for the quarter, compared to the consensus estimate of $172.12 million. Medidata Solutions had a return on equity of 9.28% and a net margin of 7.99%. Medidata Solutions’s quarterly revenue was up 16.3% compared to the same quarter last year. During the same period in the previous year, the business earned $0.40 earnings per share. On average, equities analysts anticipate that Medidata Solutions will post 0.79 earnings per share for the current fiscal year.

In other news, Director Robert Taylor sold 3,294 shares of the business’s stock in a transaction on Thursday, June 6th. The stock was sold at an average price of $90.88, for a total value of $299,358.72. Following the completion of the transaction, the director now directly owns 41,757 shares of the company’s stock, valued at $3,794,876.16. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 4.70% of the company’s stock.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc increased its holdings in shares of Medidata Solutions by 2.8% during the third quarter. Vanguard Group Inc now owns 5,200,744 shares of the company’s stock valued at $381,266,000 after acquiring an additional 142,687 shares in the last quarter. Oppenheimer Asset Management Inc. acquired a new position in shares of Medidata Solutions during the fourth quarter valued at about $90,000. Rhumbline Advisers increased its holdings in shares of Medidata Solutions by 62.8% during the fourth quarter. Rhumbline Advisers now owns 183,326 shares of the company’s stock valued at $12,360,000 after acquiring an additional 70,690 shares in the last quarter. Benjamin F. Edwards & Company Inc. increased its holdings in shares of Medidata Solutions by 127.2% during the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 945 shares of the company’s stock valued at $64,000 after acquiring an additional 529 shares in the last quarter. Finally, State Board of Administration of Florida Retirement System increased its holdings in shares of Medidata Solutions by 3.1% during the fourth quarter. State Board of Administration of Florida Retirement System now owns 36,485 shares of the company’s stock valued at $2,460,000 after acquiring an additional 1,103 shares in the last quarter.

About Medidata Solutions

Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management.

Further Reading: Return On Assets

The Fly

Analyst Recommendations for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply